The Ainslie Lab is pleased to announce we were just awarded a collaborative NIH R01 with Lead Investigator Dr. Shawn Hingtgen (UNC Eshelman School of Pharmacy). The award is titled: “Nanofiber matrices to improve neural stem cell-mediated cancer therapy”. We will be fabricating nanofiber matrices to deliver stem cells for treatment of Glioblastoma, a type of brain cancer.
The Ainslie Lab is happy to announce we were just awarded a collaborative NIH R01 with Lead Investigator Dr. Shawn Hingtgen.
Comments are closed.